Effects of consumption of the test food on liver function: A randomized double-blind placebo-controlled trial - Effects of consumption of the test food on liver function

ORTHOMEDICO Inc.0 个研究点目标入组 68 人开始时间: 2020年1月30日最近更新: 2023年10月17日

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Subjects who have a history of the severe liver disorder (viral hepatitis, drug-induced liver injury, cirrhosis) or are currently suspected to have a liver disorder (a positive test result on hepatitis screening, etc.) 3. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 4. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, bladder diseases, or any other chronic diseases 5. Subjects who suffered or have been suffered from diseases related to the biliary tract 6. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 7. Currently taking medicines and/or herbal medicines, particularly using anticoagulants such as Warfarin. 8. Subjects who are allergic to medicines and/or the test food related products 9. Subjects who are pregnant, breast-feeding, and planning to become pregnant 10. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 11. Subjects who are judged as ineligible to participate in the study by the physician

发起方